Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT03700801

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03700801
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03700801. Non-randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2019-12-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Triple combination therapy group
Intervention (Drug)
Premixed insulin therapy group
Lead sponsor
Zhujiang Hospital (class: other)
Collaborator
The Sixth Affiliated Hospital of Guangzhou Medical University (class: other)
Collaborator
Third Affiliated Hospital, Sun Yat-Sen University (class: other)
Collaborator
Peking University Shenzhen Hospital (class: other)
Collaborator
Dongguan Kanghua Hospital (class: other)
Collaborator
First People's Hospital, Shunde China (class: other)
Collaborator
The First Affiliated Hospital of Guangdong Pharmaceutical University (class: other)
Collaborator
The Fifth Affiliated Hospital of Zunyi Medical College (class: other)
Collaborator
Shenzhen Sixth People's Hospital (class: other)

Record details

Record id
cardio:ct-nct03700801
Content hash
c50ae1c6220dac82bfd4c69e6660cb773af0d8964a5e71beb4dfa079992900b7